Monthly injection 'keeps third-biggest killer disease in the UK at bay'
Trials have shown that a monthly injection of mepolizumab significantly reduces severe symptoms of chronic obstructive pulmonary disease (COPD).
since
auto-detected in 86 stories
6 days ago
22 days ago
found
a story from Calculated Risk › Calculated Risk
27 days ago
found
a story from Calculated Risk › Calculated Risk
43 days ago
found
a story from Calculated Risk › Calculated Risk
48 days ago
found
a story from Calculated Risk › Calculated Risk
54 days ago
found
a story from Calculated Risk › Calculated Risk
55 days ago
found
a story from Calculated Risk › Calculated Risk
3 months ago
found
a story from Calculated Risk › Calculated Risk
Even though there is some uncertainty about the near-term Fed rate outlook and even though we have a F…
found
a story from Calculated Risk › Calculated Risk
4 months ago
found
a story from Calculated Risk › Calculated Risk